A new trading day began on Monday, with SELLAS Life Sciences Group Inc (NASDAQ: SLS) stock price down -7.60% from the previous day of trading, before settling in for the closing price of $1.71. SLS’s price has ranged from $0.77 to $2.12 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 33.00%. With a float of $97.68 million, this company’s outstanding shares have now reached $99.78 million.
The extent of productivity of a business whose workforce counts for 15 workers is very important to gauge. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
SELLAS Life Sciences Group Inc (SLS) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of SELLAS Life Sciences Group Inc is 2.10%, while institutional ownership is 14.33%. The most recent insider transaction that took place on May 30 ’25, was worth 33,800. In this transaction Director of this company bought 20,000 shares at a rate of $1.69, taking the stock ownership to the 30,400 shares. Before that another transaction happened on May 22 ’25, when Company’s Director bought 20,000 for $1.80, making the entire transaction worth $36,000. This insider now owns 41,000 shares in total.
SELLAS Life Sciences Group Inc (SLS) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 33.00% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 50.68% during the next five years compared to 45.94% growth over the previous five years of trading.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) Trading Performance Indicators
Here are SELLAS Life Sciences Group Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.64.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.39, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach -0.38 in one year’s time.
Technical Analysis of SELLAS Life Sciences Group Inc (SLS)
The latest stats from [SELLAS Life Sciences Group Inc, SLS] show that its last 5-days average volume of 3.09 million was superior to 2.46 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 12.25%. Additionally, its Average True Range was 0.17.
During the past 100 days, SELLAS Life Sciences Group Inc’s (SLS) raw stochastic average was set at 57.46%, which indicates a significant increase from 28.95% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 112.53% in the past 14 days, which was higher than the 102.57% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.4232, while its 200-day Moving Average is $1.2462. Now, the first resistance to watch is $1.7500. This is followed by the second major resistance level at $1.9200. The third major resistance level sits at $2.0100. If the price goes on to break the first support level at $1.4900, it is likely to go to the next support level at $1.4000. Assuming the price breaks the second support level, the third support level stands at $1.2300.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) Key Stats
With a market capitalization of 157.65 million, the company has a total of 99,777K Shares Outstanding. Currently, annual sales are 0 K while annual income is -30,880 K. The company’s previous quarter sales were 0 K while its latest quarter income was -5,810 K.
